https://www.premera.com/medicalpolicies/5.01.599.pdf#search=policy
PHARMACY POLICY - 5.01.599 Pharmacologic Treatment of Sleep Disorders Effective Date: May ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.610.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.610 Pharmacologic Treatment in Assisted Reproduction ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.623.pdf#search=policy
PHARMACY POLICY - 5.01.623 Topical Drugs for Actinic Keratosis and Other Dermatologic ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.629_2027-01-01.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.629 Pharmacologic Treatment of Psoriasis Effective Date: Jan. 1, 2027* Last Revised: Sep. 8, 2026 Replaces: N/A *View the current policy here. ...
https://www.premera.com/medicalpolicies/5.01.649.pdf#search=policy
PHARMACY POLICY - 5.01.649 Pharmacologic Treatment of Seizures Effective Date: Jun. 1, ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.650.pdf#search=policy
MEDICAL POLICY - 5.01.650 Bispecific Antibodies Effective Date: Sep. 1, 2026 Last ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.652.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.652 Miscellaneous Pharmacologic Treatments of Psoriasis ... Medical Necessity criteria within this policy DO NOT apply to Alaska fully- insured ...
https://www.premera.com/medicalpolicies/10.01.520.pdf#search=policy
BENEFIT COVERAGE GUIDELINE - 10.01.520 Review for Coverage in the Absence of a Medical Policy, Pharmacy Policy, or Utilization Management Guideline Effective Date: Sep. 1, 2026 ...
https://www.premera.com/medicalpolicies/15.01.003.pdf#search=policy
ROUTINE TEST MANAGEMENT POLICY - 15.01.003 Thyroid Disease Testing Ref. Policy: G2045 Effective Date: Feb. 6, 2026 Last Revised: Feb. 6, 2026 Replaces: N/A RELATED POLICIES: N/A ...
https://www.premera.com/medicalpolicies/15.01.042.pdf#search=policy
ROUTINE TEST MANAGEMENT POLICY - 15.01.042 Serum Tumor Markers for Malignancies Ref. Policy: G2124 Effective Date: Feb. 6, 2026 Last Revised: Oct. 1, 2026 Replaces: N/A RELATED ...
https://www.premera.com/medicalpolicies/2.04.521.pdf#search=policy
MEDICAL POLICY - 2.04.521 Evaluation of Biomarkers for Alzheimer Disease BCBSA Ref. Policy: 2.04.14 Effective Date: Aug. 1, 2025* Last Revised: Jan. 1, 2026 Replaces: N/A *This ...
https://www.premera.com/medicalpolicies/5.01.536.pdf#search=policy
MEDICAL POLICY - 5.01.536 Nulojix (belatacept) for Adults Effective Date: Jun. 1, 2026 ... Medical Necessity criteria within this policy DOES NOT apply to Alaska fully- insured ...
https://www.premera.com/medicalpolicies/5.01.662.pdf#search=policy
PHARMACY POLICY - 5.01.662 Antiemetic Medications Effective Date: Aug. 1, 2026 Last ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/7.03.13.pdf#search=policy
MEDICAL POLICY - 7.03.13 Composite Tissue Allotransplantation of the Hand and Face BCBSA Ref. Policy: 7.03.13 Effective Date: Dec. 1, 2025 Last Revised: Nov. 10, 2025 Replaces: N/...
https://www.premera.com/medicalpolicies/5.01.578.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.578 Amyotrophic Lateral Sclerosis (ALS) Medications ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.621.pdf#search=policy
PHARMACY POLICY - 5.01.621 Drugs for Weight Management Effective Date: Sep. 1, 2026 Last ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.632.pdf#search=policy
MEDICAL POLICY - 5.01.632 Pharmacologic Treatment of Bladder Cancer Effective Date: Jul. ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.634.pdf#search=policy
MEDICAL POLICY - 5.01.634 Gene Therapies for Cerebral Adrenoleukodystrophy BCBSA Ref. Policy: 5.01.45 Effective Date: Jul. 1, 2026 Last Revised: Jun. 8, 2026 Replaces: N/A RELATED ...
https://www.premera.com/medicalpolicies/1.01.530.pdf#search=policy
MEDICAL POLICY - 1.01.530 Children's Therapeutic Positioning Equipment Effective Date: ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/15.01.022.pdf#search=policy
ROUTINE TEST MANAGEMENT POLICY - 15.01.022 Nerve Fiber Density Testing Ref. Policy: M2112 Effective Date: Feb. 6, 2026 Last Revised: Feb. 6, 2026 Replaces: N/A RELATED POLICIES: N/...